Gfi1在慢性粒细胞白血病中的表达及对32D细胞增殖作用的影响
|
摘要
目的：建立测定人类Gfi1mRNA表达量的SYBR GreenⅠ实时荧光定量PCR方法,为进一步研究新基因的功能奠定基础。
方法：以Gfi1基因为靶基因设计引物。构建携带Gfi1cDNA的质粒pLOX-Gfi1,经过纯化,质粒浓度测定,拷贝数的计算及10倍的梯度稀释制备标准品。应用ABI steponePCR仪对Gfi1进行实时荧光定量PCR检测,建立标准曲线和熔解曲线。
结果：建立了Gfi1mRNA表达的实时荧光定量PCR方法,本法线性范围为6.36x102-6.36×108copies/μl,线性相关系数γ2为0.996,熔解曲线为单峰,Tm值为(89.98±0.22)℃,标准品的循环阈值批内变异系数和批间变异系数分别为1.35%-3.61%和1.49%-3.42%。
结论：本研究建立的Gfi1mRNA表达实时荧光定量PCR检测方法速度快,灵敏度高,特异性强,重复性及稳定性好,可用于Gfi1基因的定量检测。
目的：研究Gfil在慢性粒细胞白血病患者中的表达情况,了解慢性粒细胞白血病经骨髓移植或格列卫治疗后Gfi1表达的变化,以及Gfi1与BCR/ABL表达的关系,探讨Gfi1在CML发生和发展中的作用。
方法：1.实时荧光定量PCR法检测99例慢性粒细胞白血病患者单个核细胞中Gfi1 mRNA的表达情况,包括CML-CP62例,CML-AP/BC9例,有21例CML-CP的患者进行骨髓移植,7例给予格列卫治疗,11例正常健康供者作对照；
2.流式细胞仪分选骨髓单个核细胞中CD34+细胞,包括6例CML,9例正常对照,采用实时荧光定量PCR法及western-blot法检测Gfi1 mRNA及蛋白的表达；
3.实时荧光定量PCR法检测CML患者骨髓单个核细胞BCR/ABL融合基因的表达情况；
4.采用Prism3软件对数据进行统计学处理。
结果：1.CML患者慢性期骨髓单个核细胞Gfi1 mRNA的表达为2.042,而正常对照为0.342,其表达明显增高p=0.005；尽管加速期和急变期Gfi1的表达也有所增加,但是增加的程度与疾病的进展没有很大的关系,CML-AP/BC:正常的P值为0.012,CML-CP:CML-AP/BC的P值为0.189；
2.对21例进行异基因造血干细胞移植的患者移植前Gfi1 mRNA的表达为2.242,移植后为0.368,P<0.0001；7例格列卫治疗前Gfi1 mRNA的表达为2.891,治疗后为0.208下降约10倍,P=0.014；
3.CML患者骨髓单个核CD34+的细胞中Gfi1 mRNA的表达比正常对照显著升高p=0.026；
4.BCR/ABL融合基因与Gfi1 mRNA的表达水平具有显著的相关性(r2=0.65,p<0.0001)；
5.通过流式细胞分析,我们发现CML患者慢性期骨髓单个核细胞及CD34+细胞Gfi1的蛋白表达水平比正常对照组明显升高；
6.western blot检测显示CML患者慢性期CD34+细胞Gfi1的蛋白表达水平比正常对照明显升高。
结论：慢性粒细胞白血病患者Gfi1mRNA和蛋白水平的表达明显上调,治疗后Gfi1转录本会明显下降,并且与BCR/ABL的表达具有显著的相关性。Gfi1可能是慢性粒细胞白血病的致病因子,慢性粒细胞白血病患者BCR/ABL融合基因形成导致ABL酪氨酸蛋白激酶活化可能引起Gfi1表达的改变。
目的：研究慢病毒介导人Gfi1在32D细胞的表达,建立稳定高表达Gfi1的32D细胞株,观察其对32D细胞增殖的影响。
方法：制备完整的重组慢病毒载体三质粒系统：转移质粒(pLOX-Gfi1/pLOX),包装质粒(pCMVAR8.2)及包膜蛋白质粒(pMD.G),共转染293T细胞,获得慢病毒颗粒,病毒滴度测定,并转染32D细胞,无菌流式分选获取稳定高表达Gfi1的32D细胞,采用细胞计数法,集落形成实验检测Gfi1对32D细胞增殖的影响。
结果：(1)慢病毒的三种质粒可以高效转染293T细胞,并成功包装出高滴度慢病毒,病毒滴度在3.5×105TU/ml-4.3×105TU/ml之间,可满足后续实验需要；(2)Western-blot能检测到Gfi1蛋白在及32D细胞中的表达,获得稳定表达Gfi1的32D细胞克隆；(3)低浓度IL-3细胞增殖实验显示32D/Gfi1的增殖能力增强；(4)IL-3撤退实验显示32D/Gfi1的存活能力增强；(5)软琼脂集落形成实验显示32D/Gfi1克隆形成能力增强。
结论：慢病毒介导的Gfi1基因可以高效稳定转染32D细胞,并持续表达,可以作为研究Gfi1基因功能的重要技术手段；Gfi1对32D细胞的增殖有重要影响。
Objective:To establish SYBR Green I real-time fluorescence quantitative polymerase chain reaction method for detection of human Gfi1 mRNA expression and studying function of new gene.
Method:We designed Gfi1 specific primers and constructed plasmid pLOX-Gfi1 carring GfilcDNA,then purified,quantified spectrophotometrically,calculated copies and used a 10-fold serial dilutions of quantified plasmids.At last,we established standard curve and melting curve to measure Gfil using ABI stepone PCR instrument with real-time fluorescent polymerase chain reaction.
Result:A good linearity was found from 6.36×102 to 6.36×108 copies/μl,and the correlation coefficient was 0.996.Melting curve analysis showed a single peak,and Tm was (89.98±0.22)℃.The intraassay and interassay variation of cycle threshold was 1.35%-3.61% and 1.49%-3.42% respectively.
conclusion:SYBR Green I real-time fluorescent quantitative polymerase chain reaction of Gfi1 mRNA expression is a rapid,sensitive,specific,repeatable and stable method.It can be used to further research on human Gfi1.
Objective:To study Gfi1 expression profile in patients of chronic myelocytic leukemia (CML) before and after bone marrow transplantation or imatinib treatment. To study the relationship of Gfi1 expression and BCR/ABL, to probe the Gfi1 function in the pathogenesis of CML.
Methods:1.Quantitative real time PCR was performed to quantify the Gfil mRNA in CML patients, which included 62 cases of CML-CP without any treatment,9 cases of CML-AP/ BC without treatment,21 cases of CML-CP after bone marrow transplantation,7 cases after imatinib treatment and 11 healthy volunteers; 2.CD34+ cells were separated from monocytes by flowcytometry from 6 patients of CML and 9 healthy donors. Sorted cells were analyzed by real time PCR to quantify mRNA of Gfi1 and Western-blot was performed to analyze the Gfi1 protein expression; 3.Quantitative real time PCR was used to quantify mRNA of BCR/ABL fusion gene in monocytes of CML patients; 4.Statistics was performed by software Prism3.
Result:1.The mRNA expression of Gfil in mononuclear cells was significantly higher in comparison to healthy control group as determined by qPCR (2.041 vs.0.342, p= 0.005).Although patients in accelerated phase or blast crisis phase also exhibited increased expression of Gfi1, the progression of the disease from chronic phase to more advanced stage was not accompanied by more profound change of Gfi1 expression level (p=0.012 for CML-AP/BC vs. control and p=0.189 for CML-CP vs. CML-AP/BC); 2.The qPCR results showed that the mean Gfil mRNA level in 21 patients decreased from 2.242 before transplant to 0.368 after transplant (p<0.0001).Severn patients receiving imatinib and more than 10-fold reduction in Gfil mRNA expression after imatinib treatment.(2.891 vs.0.208, p=0.014); 3.Compared to healthy donors, Gfil mRNA expression is higher in CD34+BMMC of CML patients; 4.BCR/ABL expression is highly related to Gfi1mRNA expression (r2=0.65,p<0.0001); 5.Compared to healthy donors, Gfi1 protein expression is higher in CML patients BMMC and CD34+ cell by flowcytometry; 6.Gfi1 expression is higher in CD34+ cells of CML than healthy volunteers by western-blot.
Conclusion:Gfi1 mRNA and proteins expression increased dramatically in CML patients. Gfil expression decreased after treatment and was related to expression of BCR/ABL. Those results suggested that Gfi1 is involved in the pathogenesis of CML, whose expression profile is affected by the activation of ABL tyrosine kinase caused by the expression of BCR/ABL.
Objective:To establish an efficient human Gfi1 expressing 32D cell line by lentiviral mediated delivery system, study expression profile and effect of proliferation in 32D cells.
Methods:293T cells were tranfected with recombinant lentiviral system plasmids, which included Gfi1 encoding plamid pLOX-Gfi1/pLOX, packaging plasmid pCMV△R8.2 and envelope encoding plasmid pMD.G.Recombinant virus was harvested and titrated.Gfi1 expressing 32D cells were selected FACS.Viable cell counting and colony forming units were performed to analyze the effect of Gfi1 on the proliferation of 32D cells.
Results:(1)High titer (3.5×105TU/ml-4.3×105TU/ml) of recombinant Gfi1 virus was obtained by cotransfection of lentiviral plamids to 293T cells.(2)Expression of Gfi1 was detected by Westerblot after recombinant virus infection of 32D cells.(3)Low concentration of IL-3 favored the proliferation of 32D/Gfi1cells;(4)Viability of 32D/Gfi1 cells was enhanced even after IL-3 retraction;(5)More colonies forming units were detected in 32D/Gfi1.
Conclusion:Gfi1 expressed efficiently in 32D cells when delivered by lentiviral system. Gfi1 played an important role in the proliferation of 32D cells.
方法：以Gfi1基因为靶基因设计引物。构建携带Gfi1cDNA的质粒pLOX-Gfi1,经过纯化,质粒浓度测定,拷贝数的计算及10倍的梯度稀释制备标准品。应用ABI steponePCR仪对Gfi1进行实时荧光定量PCR检测,建立标准曲线和熔解曲线。
结果：建立了Gfi1mRNA表达的实时荧光定量PCR方法,本法线性范围为6.36x102-6.36×108copies/μl,线性相关系数γ2为0.996,熔解曲线为单峰,Tm值为(89.98±0.22)℃,标准品的循环阈值批内变异系数和批间变异系数分别为1.35%-3.61%和1.49%-3.42%。
结论：本研究建立的Gfi1mRNA表达实时荧光定量PCR检测方法速度快,灵敏度高,特异性强,重复性及稳定性好,可用于Gfi1基因的定量检测。
目的：研究Gfil在慢性粒细胞白血病患者中的表达情况,了解慢性粒细胞白血病经骨髓移植或格列卫治疗后Gfi1表达的变化,以及Gfi1与BCR/ABL表达的关系,探讨Gfi1在CML发生和发展中的作用。
方法：1.实时荧光定量PCR法检测99例慢性粒细胞白血病患者单个核细胞中Gfi1 mRNA的表达情况,包括CML-CP62例,CML-AP/BC9例,有21例CML-CP的患者进行骨髓移植,7例给予格列卫治疗,11例正常健康供者作对照；
2.流式细胞仪分选骨髓单个核细胞中CD34+细胞,包括6例CML,9例正常对照,采用实时荧光定量PCR法及western-blot法检测Gfi1 mRNA及蛋白的表达；
3.实时荧光定量PCR法检测CML患者骨髓单个核细胞BCR/ABL融合基因的表达情况；
4.采用Prism3软件对数据进行统计学处理。
结果：1.CML患者慢性期骨髓单个核细胞Gfi1 mRNA的表达为2.042,而正常对照为0.342,其表达明显增高p=0.005；尽管加速期和急变期Gfi1的表达也有所增加,但是增加的程度与疾病的进展没有很大的关系,CML-AP/BC:正常的P值为0.012,CML-CP:CML-AP/BC的P值为0.189；
2.对21例进行异基因造血干细胞移植的患者移植前Gfi1 mRNA的表达为2.242,移植后为0.368,P<0.0001；7例格列卫治疗前Gfi1 mRNA的表达为2.891,治疗后为0.208下降约10倍,P=0.014；
3.CML患者骨髓单个核CD34+的细胞中Gfi1 mRNA的表达比正常对照显著升高p=0.026；
4.BCR/ABL融合基因与Gfi1 mRNA的表达水平具有显著的相关性(r2=0.65,p<0.0001)；
5.通过流式细胞分析,我们发现CML患者慢性期骨髓单个核细胞及CD34+细胞Gfi1的蛋白表达水平比正常对照组明显升高；
6.western blot检测显示CML患者慢性期CD34+细胞Gfi1的蛋白表达水平比正常对照明显升高。
结论：慢性粒细胞白血病患者Gfi1mRNA和蛋白水平的表达明显上调,治疗后Gfi1转录本会明显下降,并且与BCR/ABL的表达具有显著的相关性。Gfi1可能是慢性粒细胞白血病的致病因子,慢性粒细胞白血病患者BCR/ABL融合基因形成导致ABL酪氨酸蛋白激酶活化可能引起Gfi1表达的改变。
目的：研究慢病毒介导人Gfi1在32D细胞的表达,建立稳定高表达Gfi1的32D细胞株,观察其对32D细胞增殖的影响。
方法：制备完整的重组慢病毒载体三质粒系统：转移质粒(pLOX-Gfi1/pLOX),包装质粒(pCMVAR8.2)及包膜蛋白质粒(pMD.G),共转染293T细胞,获得慢病毒颗粒,病毒滴度测定,并转染32D细胞,无菌流式分选获取稳定高表达Gfi1的32D细胞,采用细胞计数法,集落形成实验检测Gfi1对32D细胞增殖的影响。
结果：(1)慢病毒的三种质粒可以高效转染293T细胞,并成功包装出高滴度慢病毒,病毒滴度在3.5×105TU/ml-4.3×105TU/ml之间,可满足后续实验需要；(2)Western-blot能检测到Gfi1蛋白在及32D细胞中的表达,获得稳定表达Gfi1的32D细胞克隆；(3)低浓度IL-3细胞增殖实验显示32D/Gfi1的增殖能力增强；(4)IL-3撤退实验显示32D/Gfi1的存活能力增强；(5)软琼脂集落形成实验显示32D/Gfi1克隆形成能力增强。
结论：慢病毒介导的Gfi1基因可以高效稳定转染32D细胞,并持续表达,可以作为研究Gfi1基因功能的重要技术手段；Gfi1对32D细胞的增殖有重要影响。
Objective:To establish SYBR Green I real-time fluorescence quantitative polymerase chain reaction method for detection of human Gfi1 mRNA expression and studying function of new gene.
Method:We designed Gfi1 specific primers and constructed plasmid pLOX-Gfi1 carring GfilcDNA,then purified,quantified spectrophotometrically,calculated copies and used a 10-fold serial dilutions of quantified plasmids.At last,we established standard curve and melting curve to measure Gfil using ABI stepone PCR instrument with real-time fluorescent polymerase chain reaction.
Result:A good linearity was found from 6.36×102 to 6.36×108 copies/μl,and the correlation coefficient was 0.996.Melting curve analysis showed a single peak,and Tm was (89.98±0.22)℃.The intraassay and interassay variation of cycle threshold was 1.35%-3.61% and 1.49%-3.42% respectively.
conclusion:SYBR Green I real-time fluorescent quantitative polymerase chain reaction of Gfi1 mRNA expression is a rapid,sensitive,specific,repeatable and stable method.It can be used to further research on human Gfi1.
Objective:To study Gfi1 expression profile in patients of chronic myelocytic leukemia (CML) before and after bone marrow transplantation or imatinib treatment. To study the relationship of Gfi1 expression and BCR/ABL, to probe the Gfi1 function in the pathogenesis of CML.
Methods:1.Quantitative real time PCR was performed to quantify the Gfil mRNA in CML patients, which included 62 cases of CML-CP without any treatment,9 cases of CML-AP/ BC without treatment,21 cases of CML-CP after bone marrow transplantation,7 cases after imatinib treatment and 11 healthy volunteers; 2.CD34+ cells were separated from monocytes by flowcytometry from 6 patients of CML and 9 healthy donors. Sorted cells were analyzed by real time PCR to quantify mRNA of Gfi1 and Western-blot was performed to analyze the Gfi1 protein expression; 3.Quantitative real time PCR was used to quantify mRNA of BCR/ABL fusion gene in monocytes of CML patients; 4.Statistics was performed by software Prism3.
Result:1.The mRNA expression of Gfil in mononuclear cells was significantly higher in comparison to healthy control group as determined by qPCR (2.041 vs.0.342, p= 0.005).Although patients in accelerated phase or blast crisis phase also exhibited increased expression of Gfi1, the progression of the disease from chronic phase to more advanced stage was not accompanied by more profound change of Gfi1 expression level (p=0.012 for CML-AP/BC vs. control and p=0.189 for CML-CP vs. CML-AP/BC); 2.The qPCR results showed that the mean Gfil mRNA level in 21 patients decreased from 2.242 before transplant to 0.368 after transplant (p<0.0001).Severn patients receiving imatinib and more than 10-fold reduction in Gfil mRNA expression after imatinib treatment.(2.891 vs.0.208, p=0.014); 3.Compared to healthy donors, Gfil mRNA expression is higher in CD34+BMMC of CML patients; 4.BCR/ABL expression is highly related to Gfi1mRNA expression (r2=0.65,p<0.0001); 5.Compared to healthy donors, Gfi1 protein expression is higher in CML patients BMMC and CD34+ cell by flowcytometry; 6.Gfi1 expression is higher in CD34+ cells of CML than healthy volunteers by western-blot.
Conclusion:Gfi1 mRNA and proteins expression increased dramatically in CML patients. Gfil expression decreased after treatment and was related to expression of BCR/ABL. Those results suggested that Gfi1 is involved in the pathogenesis of CML, whose expression profile is affected by the activation of ABL tyrosine kinase caused by the expression of BCR/ABL.
Objective:To establish an efficient human Gfi1 expressing 32D cell line by lentiviral mediated delivery system, study expression profile and effect of proliferation in 32D cells.
Methods:293T cells were tranfected with recombinant lentiviral system plasmids, which included Gfi1 encoding plamid pLOX-Gfi1/pLOX, packaging plasmid pCMV△R8.2 and envelope encoding plasmid pMD.G.Recombinant virus was harvested and titrated.Gfi1 expressing 32D cells were selected FACS.Viable cell counting and colony forming units were performed to analyze the effect of Gfi1 on the proliferation of 32D cells.
Results:(1)High titer (3.5×105TU/ml-4.3×105TU/ml) of recombinant Gfi1 virus was obtained by cotransfection of lentiviral plamids to 293T cells.(2)Expression of Gfi1 was detected by Westerblot after recombinant virus infection of 32D cells.(3)Low concentration of IL-3 favored the proliferation of 32D/Gfi1cells;(4)Viability of 32D/Gfi1 cells was enhanced even after IL-3 retraction;(5)More colonies forming units were detected in 32D/Gfi1.
Conclusion:Gfi1 expressed efficiently in 32D cells when delivered by lentiviral system. Gfi1 played an important role in the proliferation of 32D cells.
引文
[1]Gilks CB,Bear SE,Grimes HL,et al.Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation·of a gene (Gfi-1) encoding a novel zinc finger protein.Mol Cell Biol.1993,13(3):1759-1768.
[2]Schmidt T,Karsunky H,Gau E,et al. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.Oncogene.1998,17(20):2661-2667.
[3]Wallis D, Hamblen M, Zhou Y, et al.The zinc finger transcription factor Gfi1, implicated in lymphomagenesis, is required for inner ear hair cell differentiation and survival.Development 2003,130:221-232.
[4]Kazanjian A, Wallis D, Au N, et al.Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells. Cancer Res 2004,64:6874-6882.
[5]Grimes HL, Chan TO, Zweidler-McKay PA, et al. The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol Cell Biol.1996,16(11):6263-6272.
[6]Zornig M, Schmidt T, Karsunky H, et al. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2. Oncogene.1996,12(8):1789-1801.
[7]Huh HJ, Chae SL, Lee M,et al. CD34, RAB20, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome.Int J Lab Hematol.2009,31(3):344-351
[8]Yin JL, Shackel NA, Zekry A, et al. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol.2001,79(3):213-221.
[9]van der Velden VH, HochhausA, Cazzaniga G, et al. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR:principles, approaches, and laboratory aspects.Leukemia.2003,17(6):1013-1034.
[1]Druker BJ.Translation of the Philadelphia chromosome into therapy for CML. Blood.2008;112(13):4808-4817.
[2]Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, Silver RT, Goldman JM,Stone RM, Cervantes F, Hochhaus A, Powell BL, Gabrilove JL, Rousselot P, Reiffers J, Cornelissen JJ, Hughes T, Agis H, Fischer T, Verhoef G, Shepherd J, Saglio G, Gratwohl A,Nielsen JL, Radich JP, Simonsson B, Taylor K, Baccarani M, So C, Letvak L, Larson RA:Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med.2006;355 (23):2408-2417.
[3]Hochhaus A, O'Brien SG, Guilhot F, Druker BJ, Branford S, Foroni L, Goldman JM, Muller MC, Radich JP, Rudoltz M, Mone M,Gathmann I, Hughes TP, Larson RA.Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia.Leukemia.2009;23(6):1054-1061.
[4]O'Hare T, Eide CA, Deininger MW.BCR-ABL kinase domain mutations、 drug resistance、 and the road to a cure for chronic myeloid leukemia.Blood.2007; 110(7): 2242-2249.
[5]Sawyers CL, Hochhaus A, Feldman E, Goldman JM, Miller CB, Ottmann OG, Schiffer CA, Talpaz M, Guilhot F, Deininger MW,Fischer T, O'Brien SG, Stone RM, Gambacorti-Passerini CB, Russell NH, Reiffers JJ,Shea TC, Chapuis B, Coutre S, Tura S, Morra E, Larson RA, Saven A, Peschel C, GratwohlA, Mandelli F, Ben-Am M, Gathmann I,Capdeville R, Paquette RL, Druker BJ.Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis:results of a phase Ⅱ study.Blood.2002;99(10):3530-3539.
[6]Talpaz M, Silver RT, Druker BJ, Goldman JM, Gambacorti-Passerini C, Guilhot F, Schiffer CA, Fischer T, Deininger MW, Lennard AL, Hochhaus A, Ottmann OG, Gratwohl A, Baccarani M, Stone R, Tura S, Mahon FX, Fernandes-Reese S, Gathmann I,Capdeville R, Kantarjian HM, Sawyers CL.Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia:results of a phase 2 study.Blood.2002;99(6):1928-1937.
[7]Schmidt T, Karsunky H, Gau E, Zevnik B,Elsasser HP, Moroy T:Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.Oncogene.1998;17(20):2661-2667.
[8]Zornig M, Schmidt T, Karsunky H, Grzeschiczek A, Moroy T:Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.Oncogene.1996;12(8):1789-1801.
[9]Yucel R, Karsunky H, Klein-Hitpass L, Moroy T.The transcriptional repressor Gfi1 affects development of early, uncommitted ckit+T cell progenitors and CD4/CD8 lineage decision in the thymus.J Exp Med.2003;197(7):831-844.
[10]Hock H, Hamblen MJ, Rooke HM, Traver D,Bronson RT, Cameron S, Orkin SH.Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation.Immunity.2003;18(1):109-120.
[11]Karsunky H, Zeng H, Schmidt T, Zevnik B,Kluge R, Schmid KW, Duhrsen U, Moroy T. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor gfi1.Nat Genet.2002;30(3):295-300.
[12]Person RE, Li FQ, Duan Z, Benson KF,Wechsler J, Papadaki HA, Eliopoulos G, Kaufman C, Bertolone SJ, Nakamoto B, Papayannopoulou T, Grimes HL, Horwitz M. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet.2003;34(3):308-312.
[13]Hock H, Hamblen MJ, Rooke HM, Schindler JW, Saleque S, Fujiwara Y, Orkin SH.Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells.Nature.2004;431 (7011):1002-1007.
[14]Zeng H, Yucel R, Kosan C, Klein-Hitpass L, Moroy T.Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells.EMBO J.2004;23(20):4116-4125.
[15]Vassen L, Khandanpour C, Ebeling P, van der Reijden BA, Jansen JH, Mahlmann S, Diihrsen U, Moroy T:Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia.Int J Hematol.2009; 89(4):422-430.
[16]Basu S, Liu Q, Qiu Y, Dong F:Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1.Proc Natl Acad Sci USA.2009;06(5):1433-1438.
[17]Duan Z, Zarebski A, Montoya-Durango D,Grimes HL, Horwitz M.Gfil coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1. Mol Cell Biol.2005;25 (23):10338-10351.
[1]Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. A Third-Generation Lentivirus Vector with a Conditional Packaging System.Journal of Virology.1998,72(11):8463-8471.
[2]Abbas-TerkiT,Blanco-BoseW,Deglon N,et al.Lentiviru mediated RNA interference. Hum Gene Ther.2002,13(18):2197-2201
[3]Stewart SA,Dykxhoorn DM,Palliser D,et al.Lentivirus delivered stable gene silencing by RNAi in primary cells.RNA.2003,9(4):493-501
[4]Robert T,and Cowell JK,et al.Cloning of the human Gfi-1 gene and its mapping to chromosome region lp22.Oncogene.1997,14:1003-1005.
[5]Nolo R, Abbott LA, Bellen HJ. Senseless, a Zn finger transcription factor, is necessary and sufficient for sensory organ development in Drosophila. Cell 2000;102:349-362.
[6]Hock H, Hamblen MJ, Rooke HM, et al. Intrinsic requirement for zinc finger transcription factor gfi-1 in neutrophil differentiation. Immunity.2003; 18:109-120.
[7]Karsunky H, Zeng H, Schmidt T, et al. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genet.2002;30:295-300.
[8]Yucel R, Karsunky H, Klein-Hitpass L, Moroy T. The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus. J Exp Med.2003;197:831-844.
[9]Schmidt T, Karsunky H, Gau E, Zevnik B,Elsasser HP and Moroy T.Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis. Oncogene.1998,17:2661-2667.
[10]Hock H, Hamblen MJ, Rooke HM, et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature.2004;431:1002-1007.
[11]Zeng H, Yucel R, Kosan C, Klein-Hitpass L, Moroy T. Transcription factor Gfi1 regulates selfrenewal and engraftment of hematopoietic stem cells. EMBO J. 2004;23:4116-125.
[12]Person RE, Li FQ, Duan Z, et al. Gfi1 proto-oncogene mutation causes human neutropenia and targets neutrophil elastase. Nat Genet.2003;34:308-312.
[13]Frankel AD,Young JA.HIV-1:fifteen proteins and an RNA.Annu Rev Biochem.1998, 67:1-25.
[14]Skin K J.Wall E A.Zavzavadjian J R,Santat L A,Liu J,Hwang J I,et al.A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression.Proc Natl Acad Sci USA.2006,103 (37):13759-13764.
[15]Higashikawa F, Chang L. Kinetic analyses of stability of simple and complex retroviral vectors. Virology.2001;280(1):124-131.
[16]Haas DL, Case SS, Crooks GM, Kohn DB. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.Mol Ther. 2000;2(1):71-80.
[17]Pfeifer A,Hafmann A.Lentiviral transgenesis.Methods Mol Biol.2009,530:391-405
[18]刘瑞兰.动物基因工程慢病毒载体[J].渝西学院学报,2005,4(2)：54-56
[19]Lois C, Refaeli Y, Qin XF,et al. Retroviruses as tools to study the immune system. Curr Opin Immunol.2001,13(4):496-504.
[1]Nolo R,Abbott LA,Bellen HJ.Senseless,a Zn finger transcription factor,is necessary and sufficient for sensory organ development in Drosophila.Cell.2000; 102:349-62.
[2]Hock H,Hamblen MJ,Rooke HM,et al.Intrinsic requirement for zinc finger transcription factor gfi-1 in neutrophil differentiation.Immunity.2003; 18:109-20.
[3]Karsunky H,Zeng H,Schmidt T,et al.Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfil.Nat Genet.2002;30:295-300.
[4]Yucel R,Karsunky H,Klein-Hitpass L,Moroy T.The transcriptional repressor Gfil affects development of early,uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus.J Exp Med.2003;197:831-44.
[5]Hock H,Hamblen MJ,Rooke HM,et al.Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells.Nature 2004;431:1002-7.
[6]Zeng H,Yucel R,Kosan C,Klein-Hitpass L,Moroy T.Transcription factor Gfil regulates selfrenewal and engraftment of hematopoietic stem cells.EMBO J. 2004;23:4116-25.
[7]Wallis D,Hamblen M,Zhou Y,et al.The zinc finger transcription factor Gfil, implicated in lymphomagenesis,is required for inner ear hair cell differentiation and survival.Development.2003; 130:221-32.
[8]Yang Z,Ding K,Pan L,Deng M,Gan L.Math5 determines the competence state of retinal ganglion cell progenitors.Dev Biol.2003;264:240-54.
[9]Kazanjian A,Wallis D,Au N,et al.Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells.Cancer Res.2004;64:6874-82.
[10]Person RE,Li FQ,Duan Z,et al.Gfil proto-oncogene mutation causes human neutropenia and targets neutrophil elastase.Nat Genet.2003;34:308-12.
[11]CD34,RAB20,PU.1 and GFI1 mRNA expression in myelodysplastic syndrome.Huh HJ,Chae SL,Lee M,Hong KS,Mun YC,Seong CM,Chung WS,Huh JW.Int J Lab Hematol.2009;31(3):344-51.
[12]Gilks CB, Bear SE, Grimes HL, Tsichlis PN.Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol.1993; 13:1759-68.
[13]Dabrowska MJ,Dybkaer K,Johnsen HE,Wang B,Wabl M,Pedersen FS.Loss of MicroRNA targets in the 3'untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1.J Virol.2009;83(16):8051-61.
[14]Zornig M,Schmidt T,Karsunky H,Grzeschiczek A,Moroy T.Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.Oncogene.1996;12:1789-801.
[15]Schmidt T,Zornig M,Beneke R,Moroy T.MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene.Nucleic Acids Res.1996;24:2528-34.
[16]Akagi K,Suzuki T,Stephens RM,Jenkins NA,Copeland NG.RTCGD:retroviral tagged cancer gene database.Nucleic Acids Res.2004;32:D523-7.
[17]Doan LL,Kitay MK,Yu Q,et al.Growth factor independence-1B expression leads to defects in T cell activation,IL-7 receptor alpha expression,and T cell lineage commitment.J Immunol.2003;170:2356-66.
[18]Schmidt T,Karsunky H,Gau E,Zevnik B,Elsasser HP,Moroy T.Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.Oncogene.1998; 17:2661-7.
[19]Tong B,Grimes HL,Yang TY,et al.The Gfi-1B proto-oncoprotein represses p21WAFl and inhibits myeloid cell differentiation.Mol Cell Biol.1998;18:2462-73.
[20]Alkema MJ,Jacobs H,van LM,Berns A.Pertubation of B and T cell development and predisposition to lymphomagenesis in Emu Bmil transgenic mice require the Bmil RING finger.Oncogene.1997; 15:899-910.
[21]van Lohuizen M,Verbeek S,Scheijen B,Wientjens E,van der Gulden H,Berns A. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging.Cell.1991;65:737-52.
[22]Alkema MJ,van der Lugt NM,Bobeldijk RC,Berns A,van LM.Transformation of axial skeleton due to overexpression of bmi-1 in transgenic mice.Nature.1995;374:724-7.
[23]Jacobs JJ,Scheijen B,Voncken JW,Kieboom K,Berns A,van Lohuizen M.Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc- induced apoptosis via INK4a/ARF.Genes Dev.1999; 13:2678-90.
[24]Juin P,Hueber AO,Littlewood T,Evan G.c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev.1999; 13:1367-81.
[25]Grimes HL,Gilks CB,Chan TO,Porter S,Tsichlis PN.The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death.Proc Natl Acad Sci USA. 1996;93:14569-73.
[26]Karsunky H,Mende I,Schmidt T,Moroy T.High levels of the onco-protein Gfi-1 accelerate T-cell proliferation and inhibit activation induced T-cell death in Jurkat T-cells.Oncogene.2002;21:1571-9.
[27]Zweidler-McKay PA,Grimes HL,Flubacher MM,Tsichlis PN.Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor.Mol Cell Biol.1996; 16:4024-34.
[28]Batlle E,Sancho E,Franci C,et al.The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol.2000;2:84-9.
[29]Duan Z,Horwitz M.Targets of the transcriptional repressor onco-protein Gfi-l.Proc Natl Acad Sci USA.2003; 100:5932-7.
[30]Vassen L,Fiolka K,Mahlmann S,Moroy T.Direct transcriptional repression of the genes encoding the zinc-finger proteins Gfi1b and Gfi1 by Gfi1b.Nucleic Acids Res.2005;33:987-98.
[31]Doan LL,Porter SD,Duan Z,et al. Targeted transcriptional repression of Gfi1 by GFI1 and GFI1B in lymphoid cells.Nucleic Acids Res.2004;32:2508-19.
[32]Cheng T,Rodrigues N,Shen H,et al.Hematopoietic stem cell quiescence maintained by p21cip1/waf1.Science.2000;287:1804-8.
[33]Akaishi H,Takeda K,Kaisho T,et al.Defective IL-2-mediated IL-2 receptor alpha chain expression in Stat3-deficient T lymphocytes.Int Immunol 1998; 10:1747-51.
[34]Takeda K,Kaisho T,Yoshida N,Takeda J,Kishimoto T,Akira S.Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice.J Immunol. 1998;161:4652-60.
[35]Chung CD,Liao J,Liu B,et al.Specific inhibition of Stat3 signal transduction by PIAS3.Science.1997;278:1803-5.
[36]Rodel B,Tavassoli K,Karsunky H,et al.The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3.EMBO J.2000;19:5845-55.
[37]Bromberg JF,Wrzeszczynska MH,Devgan G,et al.Stat3 as an oncogene.Cell 1999; 98:295-303.
[38]Zhu J,Guo L,Min B,et al.Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation.Immunity.2002;16:733-44.
[39]Schmidt T,Karsunky H,Rodel B,Zevnik B,Elsasser HP,Moroy T.Evidence implicating Gfi-1 and Pim-1 in pre-T-cell differentiation steps associated with beta-selection. EMBOJ.1998;17:5349-59.
[40]Vassen L,Khandanpour C,Ebeling P,van der Reijden BA,Jansen JH,Mahlmann S, Duhrsen U,M6roy T.Growth factor independent 1b(Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia.
[41]Int J Hematol.2009;89(4):422-30.
[42]Horwitz M,Benson KF,Duan Z,et al.Role of neutrophil elastase in bone marrow failure syndromes:molecular genetic revival of the chalone hypothesis.Curr Opin Hematol.2003; 10:49-54.
[43]Zhang DE,Zhang P,Wang ND,Hetherington CJ,Darlington GJ,Tenen DGAbsence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice.Proc Natl Acad Sci USA. 1997;94:569-74.
[44]Yamanaka R,Barlow C,Lekstrom-Himes J,et al.Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice.Proc Natl Acad Sci USA.1997;94:13187-92.
[45]Scott EW,Simon MC,Anastasi J,Singh H.Requirement of transcription factor Pu.l in the development of multiple hematopoietic lineages.Science 1994;265:1573-7.
[46]McKercher SR,Torbett BE,Anderson KL,et al.Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities.EMBO J.1996;15:5647-58.
[47]Koh KR,Janz M,Mapara MY,et al.Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis.Blood.2004;105:3833-40.
[48]Dale DC,Person RE,Bolyard AA,et al.Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia.Blood.2000;96:2317-22.
[49]Horwitz M,Benson KF,Person RE,Aprikyan AG,Dale DC. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis.Nat Genet.1999;23:433-6.
[50]Rathinam C,Geffers R,Yucel R,et al.The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function.Immunity.2005;22: 717-28.
[51]Hertzano R,Montcouquiol M,Rashi-Elkeles S,et al.Transcription profiling of inner ears from Pou4f3(ddl/ddl) identifies Gfil as a target of the Pou4f3 deafness gene.Hum Mol Genet.2004;13:2143-53.
[52]Ito T.Differentiation and proliferation of pulmonary neuroendocrine cells. Prog Histochem Cytochem.1999;34:247-322.
[53]Borges M,Linnoila RI,van de Velde HJ,et al.An achaete-scute homologue essential for neuroendocrine differentiation in the lung.Nature.1997;386:852-5.
[54]Younossian AB,Brundler MA,Totsch M.Feasibility of the new WHO classification of pulmonary neuroendocrine tumours.Swiss Med Wkly 2002; 132:535-40.
[55]Wistuba II,Gazdar AF,Minna JD.Molecular genetics of small cell lung carcinoma. Semin Oncol.2001;28:3-13.
[56]Koutsami MK,Doussis-Anagnostopoulou I,Papavassiliou AG,Gorgoulis VG Genetic and molecular coordinates of neuroendocrine lung tumors,with emphasis on small-cell lung carcinomas.Mol Med 2002;8:419-36.
[57]Linnoila RI,Zhao B,DeMayo JL,et al.Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice. Cancer Res.2000;60:4005-9.
[58]Ito T,Udaka N,Ikeda M,Yazawa T,Kageyama R,Kitamura H. Significance of proneural basic helix-loop-helix transcription factors in neuroendocrine differentiation of fetal lung epithelial cells and lung carcinoma cells. Histol Histopathol.2001;16:335-43.
[59]Chen H,Biel MA,Borges MW,et al.Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors:transcriptional regulation by dual inhibitory regions.Cell Growth Differ.1997;8:677-86.59.Dwivedi PP,Anderson PH,Omdahl JL,Grimes HL,Morris HA,May BK. Identification of growth factor independent-1(GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cancer cells.Endocr Relat Cancer. 2005;12:351-65.
[60]Zhuang SH,Burnstein KL.Antiproliferative effect of 1 alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent Gl accumulation. Endocrinology.1998; 139:1197-207.
[61]Blutt SE,McDonnell TJ,Polek TC.Weigel NL.Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2.Endocrinology.2000;141:10-7.
[62]Jones G,Strugnell SA,DeLuca HF.Current understanding of the molecular actions of vitamin D.Physiol Rev.1998;78:1193-231.
[63]Hsu JY,Feldman D,McNeal JE,Peehl DM.Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition.Cancer Res.2001;61:2852-6.
[2]Schmidt T,Karsunky H,Gau E,et al. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.Oncogene.1998,17(20):2661-2667.
[3]Wallis D, Hamblen M, Zhou Y, et al.The zinc finger transcription factor Gfi1, implicated in lymphomagenesis, is required for inner ear hair cell differentiation and survival.Development 2003,130:221-232.
[4]Kazanjian A, Wallis D, Au N, et al.Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells. Cancer Res 2004,64:6874-6882.
[5]Grimes HL, Chan TO, Zweidler-McKay PA, et al. The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol Cell Biol.1996,16(11):6263-6272.
[6]Zornig M, Schmidt T, Karsunky H, et al. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2. Oncogene.1996,12(8):1789-1801.
[7]Huh HJ, Chae SL, Lee M,et al. CD34, RAB20, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome.Int J Lab Hematol.2009,31(3):344-351
[8]Yin JL, Shackel NA, Zekry A, et al. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I. Immunol Cell Biol.2001,79(3):213-221.
[9]van der Velden VH, HochhausA, Cazzaniga G, et al. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR:principles, approaches, and laboratory aspects.Leukemia.2003,17(6):1013-1034.
[1]Druker BJ.Translation of the Philadelphia chromosome into therapy for CML. Blood.2008;112(13):4808-4817.
[2]Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, Silver RT, Goldman JM,Stone RM, Cervantes F, Hochhaus A, Powell BL, Gabrilove JL, Rousselot P, Reiffers J, Cornelissen JJ, Hughes T, Agis H, Fischer T, Verhoef G, Shepherd J, Saglio G, Gratwohl A,Nielsen JL, Radich JP, Simonsson B, Taylor K, Baccarani M, So C, Letvak L, Larson RA:Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med.2006;355 (23):2408-2417.
[3]Hochhaus A, O'Brien SG, Guilhot F, Druker BJ, Branford S, Foroni L, Goldman JM, Muller MC, Radich JP, Rudoltz M, Mone M,Gathmann I, Hughes TP, Larson RA.Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia.Leukemia.2009;23(6):1054-1061.
[4]O'Hare T, Eide CA, Deininger MW.BCR-ABL kinase domain mutations、 drug resistance、 and the road to a cure for chronic myeloid leukemia.Blood.2007; 110(7): 2242-2249.
[5]Sawyers CL, Hochhaus A, Feldman E, Goldman JM, Miller CB, Ottmann OG, Schiffer CA, Talpaz M, Guilhot F, Deininger MW,Fischer T, O'Brien SG, Stone RM, Gambacorti-Passerini CB, Russell NH, Reiffers JJ,Shea TC, Chapuis B, Coutre S, Tura S, Morra E, Larson RA, Saven A, Peschel C, GratwohlA, Mandelli F, Ben-Am M, Gathmann I,Capdeville R, Paquette RL, Druker BJ.Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis:results of a phase Ⅱ study.Blood.2002;99(10):3530-3539.
[6]Talpaz M, Silver RT, Druker BJ, Goldman JM, Gambacorti-Passerini C, Guilhot F, Schiffer CA, Fischer T, Deininger MW, Lennard AL, Hochhaus A, Ottmann OG, Gratwohl A, Baccarani M, Stone R, Tura S, Mahon FX, Fernandes-Reese S, Gathmann I,Capdeville R, Kantarjian HM, Sawyers CL.Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia:results of a phase 2 study.Blood.2002;99(6):1928-1937.
[7]Schmidt T, Karsunky H, Gau E, Zevnik B,Elsasser HP, Moroy T:Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.Oncogene.1998;17(20):2661-2667.
[8]Zornig M, Schmidt T, Karsunky H, Grzeschiczek A, Moroy T:Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.Oncogene.1996;12(8):1789-1801.
[9]Yucel R, Karsunky H, Klein-Hitpass L, Moroy T.The transcriptional repressor Gfi1 affects development of early, uncommitted ckit+T cell progenitors and CD4/CD8 lineage decision in the thymus.J Exp Med.2003;197(7):831-844.
[10]Hock H, Hamblen MJ, Rooke HM, Traver D,Bronson RT, Cameron S, Orkin SH.Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation.Immunity.2003;18(1):109-120.
[11]Karsunky H, Zeng H, Schmidt T, Zevnik B,Kluge R, Schmid KW, Duhrsen U, Moroy T. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor gfi1.Nat Genet.2002;30(3):295-300.
[12]Person RE, Li FQ, Duan Z, Benson KF,Wechsler J, Papadaki HA, Eliopoulos G, Kaufman C, Bertolone SJ, Nakamoto B, Papayannopoulou T, Grimes HL, Horwitz M. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet.2003;34(3):308-312.
[13]Hock H, Hamblen MJ, Rooke HM, Schindler JW, Saleque S, Fujiwara Y, Orkin SH.Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells.Nature.2004;431 (7011):1002-1007.
[14]Zeng H, Yucel R, Kosan C, Klein-Hitpass L, Moroy T.Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells.EMBO J.2004;23(20):4116-4125.
[15]Vassen L, Khandanpour C, Ebeling P, van der Reijden BA, Jansen JH, Mahlmann S, Diihrsen U, Moroy T:Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia.Int J Hematol.2009; 89(4):422-430.
[16]Basu S, Liu Q, Qiu Y, Dong F:Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1.Proc Natl Acad Sci USA.2009;06(5):1433-1438.
[17]Duan Z, Zarebski A, Montoya-Durango D,Grimes HL, Horwitz M.Gfil coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1. Mol Cell Biol.2005;25 (23):10338-10351.
[1]Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. A Third-Generation Lentivirus Vector with a Conditional Packaging System.Journal of Virology.1998,72(11):8463-8471.
[2]Abbas-TerkiT,Blanco-BoseW,Deglon N,et al.Lentiviru mediated RNA interference. Hum Gene Ther.2002,13(18):2197-2201
[3]Stewart SA,Dykxhoorn DM,Palliser D,et al.Lentivirus delivered stable gene silencing by RNAi in primary cells.RNA.2003,9(4):493-501
[4]Robert T,and Cowell JK,et al.Cloning of the human Gfi-1 gene and its mapping to chromosome region lp22.Oncogene.1997,14:1003-1005.
[5]Nolo R, Abbott LA, Bellen HJ. Senseless, a Zn finger transcription factor, is necessary and sufficient for sensory organ development in Drosophila. Cell 2000;102:349-362.
[6]Hock H, Hamblen MJ, Rooke HM, et al. Intrinsic requirement for zinc finger transcription factor gfi-1 in neutrophil differentiation. Immunity.2003; 18:109-120.
[7]Karsunky H, Zeng H, Schmidt T, et al. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genet.2002;30:295-300.
[8]Yucel R, Karsunky H, Klein-Hitpass L, Moroy T. The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus. J Exp Med.2003;197:831-844.
[9]Schmidt T, Karsunky H, Gau E, Zevnik B,Elsasser HP and Moroy T.Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis. Oncogene.1998,17:2661-2667.
[10]Hock H, Hamblen MJ, Rooke HM, et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature.2004;431:1002-1007.
[11]Zeng H, Yucel R, Kosan C, Klein-Hitpass L, Moroy T. Transcription factor Gfi1 regulates selfrenewal and engraftment of hematopoietic stem cells. EMBO J. 2004;23:4116-125.
[12]Person RE, Li FQ, Duan Z, et al. Gfi1 proto-oncogene mutation causes human neutropenia and targets neutrophil elastase. Nat Genet.2003;34:308-312.
[13]Frankel AD,Young JA.HIV-1:fifteen proteins and an RNA.Annu Rev Biochem.1998, 67:1-25.
[14]Skin K J.Wall E A.Zavzavadjian J R,Santat L A,Liu J,Hwang J I,et al.A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression.Proc Natl Acad Sci USA.2006,103 (37):13759-13764.
[15]Higashikawa F, Chang L. Kinetic analyses of stability of simple and complex retroviral vectors. Virology.2001;280(1):124-131.
[16]Haas DL, Case SS, Crooks GM, Kohn DB. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.Mol Ther. 2000;2(1):71-80.
[17]Pfeifer A,Hafmann A.Lentiviral transgenesis.Methods Mol Biol.2009,530:391-405
[18]刘瑞兰.动物基因工程慢病毒载体[J].渝西学院学报,2005,4(2)：54-56
[19]Lois C, Refaeli Y, Qin XF,et al. Retroviruses as tools to study the immune system. Curr Opin Immunol.2001,13(4):496-504.
[1]Nolo R,Abbott LA,Bellen HJ.Senseless,a Zn finger transcription factor,is necessary and sufficient for sensory organ development in Drosophila.Cell.2000; 102:349-62.
[2]Hock H,Hamblen MJ,Rooke HM,et al.Intrinsic requirement for zinc finger transcription factor gfi-1 in neutrophil differentiation.Immunity.2003; 18:109-20.
[3]Karsunky H,Zeng H,Schmidt T,et al.Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfil.Nat Genet.2002;30:295-300.
[4]Yucel R,Karsunky H,Klein-Hitpass L,Moroy T.The transcriptional repressor Gfil affects development of early,uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus.J Exp Med.2003;197:831-44.
[5]Hock H,Hamblen MJ,Rooke HM,et al.Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells.Nature 2004;431:1002-7.
[6]Zeng H,Yucel R,Kosan C,Klein-Hitpass L,Moroy T.Transcription factor Gfil regulates selfrenewal and engraftment of hematopoietic stem cells.EMBO J. 2004;23:4116-25.
[7]Wallis D,Hamblen M,Zhou Y,et al.The zinc finger transcription factor Gfil, implicated in lymphomagenesis,is required for inner ear hair cell differentiation and survival.Development.2003; 130:221-32.
[8]Yang Z,Ding K,Pan L,Deng M,Gan L.Math5 determines the competence state of retinal ganglion cell progenitors.Dev Biol.2003;264:240-54.
[9]Kazanjian A,Wallis D,Au N,et al.Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells.Cancer Res.2004;64:6874-82.
[10]Person RE,Li FQ,Duan Z,et al.Gfil proto-oncogene mutation causes human neutropenia and targets neutrophil elastase.Nat Genet.2003;34:308-12.
[11]CD34,RAB20,PU.1 and GFI1 mRNA expression in myelodysplastic syndrome.Huh HJ,Chae SL,Lee M,Hong KS,Mun YC,Seong CM,Chung WS,Huh JW.Int J Lab Hematol.2009;31(3):344-51.
[12]Gilks CB, Bear SE, Grimes HL, Tsichlis PN.Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol.1993; 13:1759-68.
[13]Dabrowska MJ,Dybkaer K,Johnsen HE,Wang B,Wabl M,Pedersen FS.Loss of MicroRNA targets in the 3'untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1.J Virol.2009;83(16):8051-61.
[14]Zornig M,Schmidt T,Karsunky H,Grzeschiczek A,Moroy T.Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.Oncogene.1996;12:1789-801.
[15]Schmidt T,Zornig M,Beneke R,Moroy T.MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene.Nucleic Acids Res.1996;24:2528-34.
[16]Akagi K,Suzuki T,Stephens RM,Jenkins NA,Copeland NG.RTCGD:retroviral tagged cancer gene database.Nucleic Acids Res.2004;32:D523-7.
[17]Doan LL,Kitay MK,Yu Q,et al.Growth factor independence-1B expression leads to defects in T cell activation,IL-7 receptor alpha expression,and T cell lineage commitment.J Immunol.2003;170:2356-66.
[18]Schmidt T,Karsunky H,Gau E,Zevnik B,Elsasser HP,Moroy T.Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.Oncogene.1998; 17:2661-7.
[19]Tong B,Grimes HL,Yang TY,et al.The Gfi-1B proto-oncoprotein represses p21WAFl and inhibits myeloid cell differentiation.Mol Cell Biol.1998;18:2462-73.
[20]Alkema MJ,Jacobs H,van LM,Berns A.Pertubation of B and T cell development and predisposition to lymphomagenesis in Emu Bmil transgenic mice require the Bmil RING finger.Oncogene.1997; 15:899-910.
[21]van Lohuizen M,Verbeek S,Scheijen B,Wientjens E,van der Gulden H,Berns A. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging.Cell.1991;65:737-52.
[22]Alkema MJ,van der Lugt NM,Bobeldijk RC,Berns A,van LM.Transformation of axial skeleton due to overexpression of bmi-1 in transgenic mice.Nature.1995;374:724-7.
[23]Jacobs JJ,Scheijen B,Voncken JW,Kieboom K,Berns A,van Lohuizen M.Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc- induced apoptosis via INK4a/ARF.Genes Dev.1999; 13:2678-90.
[24]Juin P,Hueber AO,Littlewood T,Evan G.c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev.1999; 13:1367-81.
[25]Grimes HL,Gilks CB,Chan TO,Porter S,Tsichlis PN.The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death.Proc Natl Acad Sci USA. 1996;93:14569-73.
[26]Karsunky H,Mende I,Schmidt T,Moroy T.High levels of the onco-protein Gfi-1 accelerate T-cell proliferation and inhibit activation induced T-cell death in Jurkat T-cells.Oncogene.2002;21:1571-9.
[27]Zweidler-McKay PA,Grimes HL,Flubacher MM,Tsichlis PN.Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor.Mol Cell Biol.1996; 16:4024-34.
[28]Batlle E,Sancho E,Franci C,et al.The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol.2000;2:84-9.
[29]Duan Z,Horwitz M.Targets of the transcriptional repressor onco-protein Gfi-l.Proc Natl Acad Sci USA.2003; 100:5932-7.
[30]Vassen L,Fiolka K,Mahlmann S,Moroy T.Direct transcriptional repression of the genes encoding the zinc-finger proteins Gfi1b and Gfi1 by Gfi1b.Nucleic Acids Res.2005;33:987-98.
[31]Doan LL,Porter SD,Duan Z,et al. Targeted transcriptional repression of Gfi1 by GFI1 and GFI1B in lymphoid cells.Nucleic Acids Res.2004;32:2508-19.
[32]Cheng T,Rodrigues N,Shen H,et al.Hematopoietic stem cell quiescence maintained by p21cip1/waf1.Science.2000;287:1804-8.
[33]Akaishi H,Takeda K,Kaisho T,et al.Defective IL-2-mediated IL-2 receptor alpha chain expression in Stat3-deficient T lymphocytes.Int Immunol 1998; 10:1747-51.
[34]Takeda K,Kaisho T,Yoshida N,Takeda J,Kishimoto T,Akira S.Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice.J Immunol. 1998;161:4652-60.
[35]Chung CD,Liao J,Liu B,et al.Specific inhibition of Stat3 signal transduction by PIAS3.Science.1997;278:1803-5.
[36]Rodel B,Tavassoli K,Karsunky H,et al.The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3.EMBO J.2000;19:5845-55.
[37]Bromberg JF,Wrzeszczynska MH,Devgan G,et al.Stat3 as an oncogene.Cell 1999; 98:295-303.
[38]Zhu J,Guo L,Min B,et al.Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation.Immunity.2002;16:733-44.
[39]Schmidt T,Karsunky H,Rodel B,Zevnik B,Elsasser HP,Moroy T.Evidence implicating Gfi-1 and Pim-1 in pre-T-cell differentiation steps associated with beta-selection. EMBOJ.1998;17:5349-59.
[40]Vassen L,Khandanpour C,Ebeling P,van der Reijden BA,Jansen JH,Mahlmann S, Duhrsen U,M6roy T.Growth factor independent 1b(Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia.
[41]Int J Hematol.2009;89(4):422-30.
[42]Horwitz M,Benson KF,Duan Z,et al.Role of neutrophil elastase in bone marrow failure syndromes:molecular genetic revival of the chalone hypothesis.Curr Opin Hematol.2003; 10:49-54.
[43]Zhang DE,Zhang P,Wang ND,Hetherington CJ,Darlington GJ,Tenen DGAbsence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice.Proc Natl Acad Sci USA. 1997;94:569-74.
[44]Yamanaka R,Barlow C,Lekstrom-Himes J,et al.Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice.Proc Natl Acad Sci USA.1997;94:13187-92.
[45]Scott EW,Simon MC,Anastasi J,Singh H.Requirement of transcription factor Pu.l in the development of multiple hematopoietic lineages.Science 1994;265:1573-7.
[46]McKercher SR,Torbett BE,Anderson KL,et al.Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities.EMBO J.1996;15:5647-58.
[47]Koh KR,Janz M,Mapara MY,et al.Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis.Blood.2004;105:3833-40.
[48]Dale DC,Person RE,Bolyard AA,et al.Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia.Blood.2000;96:2317-22.
[49]Horwitz M,Benson KF,Person RE,Aprikyan AG,Dale DC. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis.Nat Genet.1999;23:433-6.
[50]Rathinam C,Geffers R,Yucel R,et al.The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function.Immunity.2005;22: 717-28.
[51]Hertzano R,Montcouquiol M,Rashi-Elkeles S,et al.Transcription profiling of inner ears from Pou4f3(ddl/ddl) identifies Gfil as a target of the Pou4f3 deafness gene.Hum Mol Genet.2004;13:2143-53.
[52]Ito T.Differentiation and proliferation of pulmonary neuroendocrine cells. Prog Histochem Cytochem.1999;34:247-322.
[53]Borges M,Linnoila RI,van de Velde HJ,et al.An achaete-scute homologue essential for neuroendocrine differentiation in the lung.Nature.1997;386:852-5.
[54]Younossian AB,Brundler MA,Totsch M.Feasibility of the new WHO classification of pulmonary neuroendocrine tumours.Swiss Med Wkly 2002; 132:535-40.
[55]Wistuba II,Gazdar AF,Minna JD.Molecular genetics of small cell lung carcinoma. Semin Oncol.2001;28:3-13.
[56]Koutsami MK,Doussis-Anagnostopoulou I,Papavassiliou AG,Gorgoulis VG Genetic and molecular coordinates of neuroendocrine lung tumors,with emphasis on small-cell lung carcinomas.Mol Med 2002;8:419-36.
[57]Linnoila RI,Zhao B,DeMayo JL,et al.Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice. Cancer Res.2000;60:4005-9.
[58]Ito T,Udaka N,Ikeda M,Yazawa T,Kageyama R,Kitamura H. Significance of proneural basic helix-loop-helix transcription factors in neuroendocrine differentiation of fetal lung epithelial cells and lung carcinoma cells. Histol Histopathol.2001;16:335-43.
[59]Chen H,Biel MA,Borges MW,et al.Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors:transcriptional regulation by dual inhibitory regions.Cell Growth Differ.1997;8:677-86.59.Dwivedi PP,Anderson PH,Omdahl JL,Grimes HL,Morris HA,May BK. Identification of growth factor independent-1(GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cancer cells.Endocr Relat Cancer. 2005;12:351-65.
[60]Zhuang SH,Burnstein KL.Antiproliferative effect of 1 alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent Gl accumulation. Endocrinology.1998; 139:1197-207.
[61]Blutt SE,McDonnell TJ,Polek TC.Weigel NL.Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2.Endocrinology.2000;141:10-7.
[62]Jones G,Strugnell SA,DeLuca HF.Current understanding of the molecular actions of vitamin D.Physiol Rev.1998;78:1193-231.
[63]Hsu JY,Feldman D,McNeal JE,Peehl DM.Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition.Cancer Res.2001;61:2852-6.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |